Skip to content

Use of the Passy Muir Swallowing Self Trainer

Study of the Use of the Passy Muir Swallowing Self Trainer by Persons With Dysphagia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02848664
Enrollment
11
Registered
2016-07-28
Start date
2013-08-31
Completion date
2015-08-31
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injury, Head and Neck Cancer, Stroke

Brief summary

The purpose of this study is to develop appropriate training methods and gather participant feedback on their use of the Passy Muir Swallowing Self-Training Device (PMSST). The PMSST is a small device that provides external vibratory stimulation to the larynx during swallowing and swallowing training. A secondary purpose of the study is to determine how 3 months of use of the PMSST affects swallowing physiology, brain activation, oral intake and quality of life. This was an uncontrolled pilot study aimed at gaining patient feedback on use of the vibratory device.

Detailed description

The investigators are currently developing the Passy Muir Swallowing Self-Trainer to continue treatment of dysphagia after the patient is discharged to home. The self-training device is worn around the neck with motors placed externally on the skin over the thyroid cartilage to provide vibratory stimulation to the larynx. The vibrations activate the sensory receptors inside the larynx which excite central nervous system (CNS) control for swallowing and can help the patient to initiate swallowing. Patients can use the self-training device at home to promote swallowing rehabilitation during daily swallowing practice. The device can also be programmed to vibrate at regular intervals throughout the day to promote saliva swallows. Using this method, the patient can continue their swallowing therapy independently and in a manner that is cost effective. A previous Phase I trial compared the clinical outcomes of 8 patients with chronic dysphagia using either an intramuscular electrical stimulation implant device or an external vibratory stimulator to practice swallowing daily at home. Functional outcomes of oral intake improved with both devices. As the external vibratory stimulation has the advantage of being external and completely noninvasive, it has been selected for further development as a self-training device. A second pilot study examined the effect of different frequencies of vibration on the swallowing frequency of healthy participants and found swallowing rate significantly increased from baseline when using a vibration of either 70 Hz or 150 Hz (Mulheren and Ludlow, 2017). Data has also been collected on the effect of different vibration characteristics on swallowing in participants who have swallowing problems after stroke (Kamarunas et al., in press). Purpose: The purpose of this study is to allow patients with chronic dysphagia to use the Self-Trainer for daily swallowing practice in their home and collect feedback on device use and satisfaction and use. Objective information on the effectiveness of self-training for swallowing rehabilitation will also be gathered. Objectives: 1. To develop and evaluate training for participants and caregivers to use the self-trainer. 2. To gather participant feedback on the use of the device after 3 months of daily practice. 3. To determine how 3 months of daily practice with the Passy Muir Swallowing Self-Trainer affects swallowing physiology, brain activation, oral intake, and quality of life in participants with chronic dysphagia.

Interventions

DEVICEDysphagia retraining with device

Patients used the device for 60 trials of retraining swallowing at home each day and also had the device turned on throughout the day in automatic mode to intermittently trigger every few minutes to trigger a swallow for saliva control

Sponsors

Passy Muir Inc.
CollaboratorINDUSTRY
James Madison University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
13 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 13 years or older * Stable medical condition * Diagnosed with oropharyngeal dysphagia confirmed by Modified Barium Swallow (MBS) baseline measure of the follow two scales: 1. Penetration-Aspiration Scale score of 2 or greater verified by modified barium swallow (Rosenbek et al., 1996) and/or 2. Functional Oral Intake Scale score of 5 or lower (Crary et al., 2005) * Folstein Mini-Mental State Examination (MMSE) score of 23 or greater indicating cognitive ability to follow directions and communicate preferences * Willingness to travel to Sentara Rockingham Memorial Hospital 2 or more times to undergo initial evaluation, device use training and checkup at 3 months.

Exclusion criteria

* Pregnancy * Cardiac problems * history of cardiac rhythm condition (including heart murmur or cardiac arrhythmia) * cardiac pacemaker in place * Highly-pigmented (dark) skin color is an exclusion criterion because near-infrared spectroscopy requires the measurement of the degree of absorption of different wavelengths of light after being reflected back through the scalp. Highly pigmented skin interferes with wavelength transmission, making the measurement of changes in absorption inaccurate. * Lack of a primary care physician who can be contacted if there are findings on the Magnetic Resonance Imaging (MRI) scan. * Presence of metal in the body (prostheses, electrodes, shrapnel, aneurism clips, other medical hardware) * Presence of certain tattoos with ferromagnetic metal or permanent makeup, due to the exposure to high magnetic force through MRI procedures. * Subjects who were metal workers as a previous occupation will also be excluded due to the possibility of unknown/undetected metal in their body. * Volunteers with broken skin in the area that the functional Near Infra-Red Spectroscopy (fNIRS) probes will be placed on the scalp * Claustrophobia * Previous surgery that used surgical staples * Artificial joints

Design outcomes

Primary

MeasureTime frameDescription
Change in Dysphagia Outcome and Severity Scale (DOSS) RatingFrom before onset of device use to return 3 months laterAn ordinal scale of 7 levels of severity of swallowing disorder with 1 being the lowest level and 7 being the highest level. Level 1 is Severe dysphagia Nothing per oral and unable to tolerate any per oral liquid/substance safely. Level 2 is Moderately severe dysphagia, requires maximum assistance or use of strategies with partial per oral only, tolerates at least one consistency safely with total use of strategies. Level 3 is Moderate Dysphagia, requires total assist, supervision, or strategies with two or more consistencies restricted. Level 4 is Mild-moderate Dysphagia, Requires intermittent supervision/cueing, one or two consistencies restricted level 5 is Mild dysphagia: requires distant supervision may need one diet consistency restricted Level 6 Within functional limits, modified independence Level 7 Normal in all situations
Dysphagia Handicap Index (DHI)From before onset of device use to return 3 months laterTotal handicap Score from 0 (no Handicap) to 100 (Severe Handicap)

Secondary

MeasureTime frameDescription
Laryngeal Elevation Relative to Hyoid Elevation for Vestibule ClosureFrom before onset of device use to return 3 months laterCalibrated kinematic measures from videofluoroscopic imaging during a modified barium swallow study. Computed the change in peak elevation in millimeters during swallowing from the rest position before swallowing for two structures: the larynx and the hyoid bone. The peak elevation of the two structures were compared by subtracting the hyoid peak elevation from the laryngeal peak elevation. If the measure was positive the larynx was elevated to a greater degree than the hyoid bone resulting in vestibule closure and airway protection during the swallow.
Cortical Activation for SwallowingFrom before onset of device use to return 3 months laterThe level of cortical activation for swallowing was measured using near infra-red spectroscopy. Overall blood oxygenation level during swallowing was compared with the level during a non activation period prior to swallowing. To compute Z scores, the change in overall level between swallowing and prior to swallowing was divided by the standard deviation of the level prior to swallowing. The Z scores measured prior to and post device use for 3 months were compared.

Countries

United States

Participant flow

Recruitment details

Potential patient participants were recruited from patients who had previously participated in protocol on The Passy Muir Swallowing Self Training Device, Voice and Swallowing Clinics, community hospitals, announcements in websites of patient support groups, and contacts with speech language pathologists specializing in dysphagia.

Pre-assignment details

Exclusion of those with psychiatric, epilepsy, severe speech/language communication disorders, cognitive impairment, esophageal disorders, and inability to tolerate a nasal endoscopic examination. Inclusion criteria: 13 years or older, parental consent if under 18, stable medical condition and oropharyngeal dysphagia.

Participants by arm

ArmCount
Laryngeal Vibrotactile Stimulation
Participants with dysphagia received external laryngeal vibrotactile stimulation to trigger swallowing for swallowing retraining. Participants received training on the device and were then given a device to take home for 3 months. Passy Muir Swallowing Self Trainer: External vibratory stimulation to the larynx to trigger swallow reflex in patients with dysphagia
7
Total7

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1
Overall Studyno assistance for device training1
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicLaryngeal Vibrotactile Stimulation
Age, Continuous56.4 years
STANDARD_DEVIATION 20.1
Functional Oral Intake Scale
1-Severe
6 Participants
Functional Oral Intake Scale
2-Moderate/Severe
1 Participants
Functional Oral Intake Scale
3-Moderate
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
6 Participants
Region of Enrollment
United States
7 participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 7
other
Total, other adverse events
3 / 7
serious
Total, serious adverse events
0 / 7

Outcome results

Primary

Change in Dysphagia Outcome and Severity Scale (DOSS) Rating

An ordinal scale of 7 levels of severity of swallowing disorder with 1 being the lowest level and 7 being the highest level. Level 1 is Severe dysphagia Nothing per oral and unable to tolerate any per oral liquid/substance safely. Level 2 is Moderately severe dysphagia, requires maximum assistance or use of strategies with partial per oral only, tolerates at least one consistency safely with total use of strategies. Level 3 is Moderate Dysphagia, requires total assist, supervision, or strategies with two or more consistencies restricted. Level 4 is Mild-moderate Dysphagia, Requires intermittent supervision/cueing, one or two consistencies restricted level 5 is Mild dysphagia: requires distant supervision may need one diet consistency restricted Level 6 Within functional limits, modified independence Level 7 Normal in all situations

Time frame: From before onset of device use to return 3 months later

Population: Patients with Severe/Moderate to Severe dysphagia, chronic for more than 6 months, nutrition is by enteric means, may be able to ingest one consistencies with supervision

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Laryngeal Vibrotactile StimulationChange in Dysphagia Outcome and Severity Scale (DOSS) RatingNo change on DOSS5 Participants
Laryngeal Vibrotactile StimulationChange in Dysphagia Outcome and Severity Scale (DOSS) RatingImprovement on DOSS2 Participants
Comparison: Examined change in DOSS for each participant from before to after three months of device use. Examined numbers of participants who showed either worsening of DOSS, no improvement in DOSS or improvement of DOSS.p-value: <0.025Wilcoxon (Mann-Whitney)
Primary

Dysphagia Handicap Index (DHI)

Total handicap Score from 0 (no Handicap) to 100 (Severe Handicap)

Time frame: From before onset of device use to return 3 months later

ArmMeasureGroupValue (MEAN)Dispersion
Laryngeal Vibrotactile StimulationDysphagia Handicap Index (DHI)Pre Device use DHI score61.143 units on a scaleStandard Deviation 17.199
Laryngeal Vibrotactile StimulationDysphagia Handicap Index (DHI)Post Use DHI Score38.571 units on a scaleStandard Deviation 22.501
p-value: 0.01695% CI: [6.003, 39.14]t-test, 2 sided
Secondary

Cortical Activation for Swallowing

The level of cortical activation for swallowing was measured using near infra-red spectroscopy. Overall blood oxygenation level during swallowing was compared with the level during a non activation period prior to swallowing. To compute Z scores, the change in overall level between swallowing and prior to swallowing was divided by the standard deviation of the level prior to swallowing. The Z scores measured prior to and post device use for 3 months were compared.

Time frame: From before onset of device use to return 3 months later

Population: Same patients before and after device use

ArmMeasureValue (MEAN)Dispersion
Laryngeal Vibrotactile StimulationCortical Activation for Swallowing18.042 Z scoreStandard Error 17.391
After Device Use for 3 MonthsCortical Activation for Swallowing70.822 Z scoreStandard Error 20.912
p-value: 0.03795% CI: [-100.751, -4.809]ANOVA
Secondary

Laryngeal Elevation Relative to Hyoid Elevation for Vestibule Closure

Calibrated kinematic measures from videofluoroscopic imaging during a modified barium swallow study. Computed the change in peak elevation in millimeters during swallowing from the rest position before swallowing for two structures: the larynx and the hyoid bone. The peak elevation of the two structures were compared by subtracting the hyoid peak elevation from the laryngeal peak elevation. If the measure was positive the larynx was elevated to a greater degree than the hyoid bone resulting in vestibule closure and airway protection during the swallow.

Time frame: From before onset of device use to return 3 months later

Population: Only 5 patients were able to undergo a repeated modified barium swallow study after device use.

ArmMeasureValue (MEAN)Dispersion
Laryngeal Vibrotactile StimulationLaryngeal Elevation Relative to Hyoid Elevation for Vestibule Closure5.525 millimetersStandard Deviation 4.338
p-value: 0.046t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026